Jones Financial Companies Lllp Has $234,000 Position in Koninklijke Philips (NYSE:PHG)

Jones Financial Companies Lllp increased its position in Koninklijke Philips (NYSE:PHG) by 18.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 9,247 shares of the technology company’s stock after buying an additional 1,426 shares during the quarter. Jones Financial Companies Lllp’s holdings in Koninklijke Philips were worth $234,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in PHG. Cable Hill Partners LLC acquired a new position in shares of Koninklijke Philips in the third quarter valued at approximately $203,000. Endowment Wealth Management Inc. acquired a new position in shares of Koninklijke Philips in the third quarter valued at approximately $205,000. PNC Financial Services Group Inc. increased its stake in shares of Koninklijke Philips by 4.8% in the third quarter. PNC Financial Services Group Inc. now owns 36,291 shares of the technology company’s stock valued at $1,187,000 after buying an additional 1,676 shares during the period. West Family Investments Inc. bought a new stake in Koninklijke Philips in the third quarter valued at approximately $252,000. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Koninklijke Philips by 26.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 55,290 shares of the technology company’s stock valued at $1,809,000 after acquiring an additional 11,538 shares during the last quarter. Institutional investors and hedge funds own 13.67% of the company’s stock.

Analyst Upgrades and Downgrades

PHG has been the topic of several analyst reports. StockNews.com upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Saturday, March 8th. UBS Group upgraded Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. Finally, BNP Paribas upgraded Koninklijke Philips from a “neutral” rating to an “outperform” rating in a report on Tuesday, February 25th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, Koninklijke Philips presently has an average rating of “Moderate Buy”.

Koninklijke Philips Price Performance

Koninklijke Philips stock opened at $26.12 on Friday. The stock has a market capitalization of $24.55 billion, a price-to-earnings ratio of -31.09, a PEG ratio of 0.82 and a beta of 0.78. Koninklijke Philips has a 52-week low of $19.10 and a 52-week high of $32.91. The stock’s 50 day moving average price is $26.62 and its two-hundred day moving average price is $27.90. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.74 and a current ratio of 1.23.

Koninklijke Philips (NYSE:PHG) last posted its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.01). The business had revenue of $5.38 billion for the quarter, compared to the consensus estimate of $5.10 billion. Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. On average, equities analysts predict that Koninklijke Philips will post 1.63 earnings per share for the current year.

Koninklijke Philips Cuts Dividend

The firm also recently declared an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Tuesday, May 13th will be issued a dividend of $0.886 per share. This represents a dividend yield of 2.9%. The ex-dividend date is Tuesday, May 13th. Koninklijke Philips’s payout ratio is -89.29%.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.